143 related articles for article (PubMed ID: 26694654)
21. TESTING MULTI-CRITERIA DECISION ANALYSIS FOR MORE TRANSPARENT RESOURCE-ALLOCATION DECISION MAKING IN COLOMBIA.
Castro Jaramillo HE; Goetghebeur M; Moreno-Mattar O
Int J Technol Assess Health Care; 2016 Jan; 32(4):307-314. PubMed ID: 27691990
[TBL] [Abstract][Full Text] [Related]
22. HEALTH TECHNOLOGY DISINVESTMENT WORLDWIDE: OVERVIEW OF PROGRAMS AND POSSIBLE DETERMINANTS.
Orso M; de Waure C; Abraha I; Nicastro C; Cozzolino F; Eusebi P; Montedori A
Int J Technol Assess Health Care; 2017 Jan; 33(2):239-250. PubMed ID: 28669355
[TBL] [Abstract][Full Text] [Related]
23. Knowledge translation and health technology reassessment: identifying synergy.
Esmail R; Hanson H; Holroyd-Leduc J; Niven DJ; Clement F
BMC Health Serv Res; 2018 Aug; 18(1):674. PubMed ID: 30165846
[TBL] [Abstract][Full Text] [Related]
24. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
25. Historical development of health technology assessment in Thailand.
Teerawattananon Y; Tantivess S; Yothasamut J; Kingkaew P; Chaisiri K
Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():241-52. PubMed ID: 19527543
[TBL] [Abstract][Full Text] [Related]
26. [Quality of health care, accreditation, and health technology assessment in Croatia: role of agency for quality and accreditation in health].
Mittermayer R; Huić M; Mestrović J
Acta Med Croatica; 2010 Dec; 64(5):425-34. PubMed ID: 21692267
[TBL] [Abstract][Full Text] [Related]
27. Identification and selection of health technologies for assessment by agencies in support of reimbursement decisions in Latin America.
Pichon-Riviere A; Augustovski F; García Martí S; Alcaraz A; Alfie V; Sampietro-Colom L
Int J Technol Assess Health Care; 2021 Aug; 37(1):e80. PubMed ID: 34392842
[TBL] [Abstract][Full Text] [Related]
28. Evidence-based decision-making 3: Health technology assessment.
O'Reilly D; Campbell K; Vanstone M; Bowen JM; Schwartz L; Assasi N; Goeree R
Methods Mol Biol; 2015; 1281():417-41. PubMed ID: 25694325
[TBL] [Abstract][Full Text] [Related]
29. The added value of applying a disinvestment approach to the process of health technology assessment in Italy.
Cadeddu C; Regazzi L; Di Brino E; Basile M; Cascini F; Paladini A; Rumi F; Cicchetti A; Ricciardi W
Int J Technol Assess Health Care; 2023 Mar; 39(1):e17. PubMed ID: 36861658
[TBL] [Abstract][Full Text] [Related]
30. Early assessment of medical technologies to inform product development and market access: a review of methods and applications.
Ijzerman MJ; Steuten LM
Appl Health Econ Health Policy; 2011 Sep; 9(5):331-47. PubMed ID: 21875163
[TBL] [Abstract][Full Text] [Related]
31. Role of health technology assessment in shaping the benefits package in The Netherlands.
Stolk EA; de Bont A; van Halteren AR; Bijlmer RJ; Poley MJ
Expert Rev Pharmacoecon Outcomes Res; 2009 Feb; 9(1):85-94. PubMed ID: 19371181
[TBL] [Abstract][Full Text] [Related]
32. Making Good Decisions in Healthcare with Multi-Criteria Decision Analysis: The Use, Current Research and Future Development of MCDA.
Mühlbacher AC; Kaczynski A
Appl Health Econ Health Policy; 2016 Feb; 14(1):29-40. PubMed ID: 26519081
[TBL] [Abstract][Full Text] [Related]
33. [More care for a limited budget; a case for a better use of the efficiency criteria].
Rutten FF; Brouwer WB
Ned Tijdschr Geneeskd; 2002 Nov; 146(47):2254-8. PubMed ID: 12481524
[TBL] [Abstract][Full Text] [Related]
34. A determination of topics for health technology assessment in Thailand: making decision makers involved.
Lertpitakpong C; Chaikledkaew U; Thavorncharoensap M; Tantivess S; Praditsitthikorn N; Youngkong S; Yothasamut J; Udomsuk K; Sinthitichai K; Teerawattananon Y
J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S100-9. PubMed ID: 19253492
[TBL] [Abstract][Full Text] [Related]
35. Development and implementation of health technology assessment in Argentina: two steps forward and one step back.
Rubinstein A; Pichon-Riviere A; Augustovski F
Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():260-9. PubMed ID: 19527545
[TBL] [Abstract][Full Text] [Related]
36. Current status of health technology reassessment of non-drug technologies: survey and key informant interviews.
Leggett LE; Mackean G; Noseworthy TW; Sutherland L; Clement F
Health Res Policy Syst; 2012 Dec; 10():38. PubMed ID: 23241276
[TBL] [Abstract][Full Text] [Related]
37. Integration of health technology assessment recommendations into organizational and clinical practice: A case study in Catalonia.
Gagnon MP; Sánchez E; Pons JM
Int J Technol Assess Health Care; 2006; 22(2):169-76. PubMed ID: 16571192
[TBL] [Abstract][Full Text] [Related]
38. Defining the scope of health technology assessment and types of health economic evaluation.
Tanvejsilp P; Ngorsuraches S
J Med Assoc Thai; 2014 May; 97 Suppl 5():S10-6. PubMed ID: 24964694
[TBL] [Abstract][Full Text] [Related]
39. Assessment of the quality of mini-HTA.
Kidholm K; Ehlers L; Korsbek L; Kjaerby R; Beck M
Int J Technol Assess Health Care; 2009 Jan; 25(1):42-8. PubMed ID: 19126250
[TBL] [Abstract][Full Text] [Related]
40. [Innovation in health care: the role of HTA in the introduction of new technologies].
Bührlen B
Z Evid Fortbild Qual Gesundhwes; 2010; 104(10):703-8. PubMed ID: 21147431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
